Nalaganje...
Damoctocog Alfa Pegol: A Review in Haemophilia A
Damoctocog alfa pegol (Jivi(®)) is approved in the USA, EU, Japan and Canada for the treatment and prophylaxis of previously treated patients aged ≥ 12 years with haemophilia A. Formulated with a 60 kDa polyethylene glycol (PEG) moiety, damoctocog alfa pegol is an intravenously (IV) administered rec...
Shranjeno v:
| izdano v: | Drugs |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer International Publishing
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6711950/ https://ncbi.nlm.nih.gov/pubmed/31218660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-019-01152-7 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|